Related Experiment Videos
Central action of amitriptyline N-oxide.
Pharmacopsychiatria
|November 1, 1982
Summary
Amitriptyline N-oxide (AMINO) and amitriptyline (AMI) both impact neurotransmitters in the brain. AMINO is a 5-HT antagonist and inhibits noradrenaline uptake, similar to AMI but at higher doses.
Area of Science:
- Neuropharmacology
- Biochemistry
- Animal Models
Background:
- Amitriptyline (AMI) is a well-established antidepressant.
- The pharmacological profile of its metabolite, amitriptyline N-oxide (AMINO), requires further elucidation.
- Understanding AMINO's central action is crucial for its therapeutic potential.
Purpose of the Study:
- To compare the biochemical and pharmacological actions of AMINO and AMI.
- To investigate their effects on noradrenaline (NA) and serotonin (5-HT) pathways.
- To determine AMINO's efficacy as a 5-HT antagonist and NA uptake inhibitor.
Main Methods:
- Biochemical assays in rat and mouse brains.
- Pharmacological challenge models in rodents.
- Assessment of neurotransmitter levels (NA, 5-HT, 5-HIAA) and behavioral responses.
Main Results:
- Both AMINO and AMI prevent 6-OH-dopamine-induced NA depletion.
- AMINO increases NA levels, while AMI decreases them; neither affects MHPG.
- AMINO and AMI potentiate p-chloroamphetamine-induced 5-HT depletion, suggesting no 5-HT reuptake inhibition.
- AMINO antagonizes 5-HTP-induced head twitches, tryptamine convulsions, fenfluramine/LSD-induced hyperthermia and reflex stimulation, and 5-HT-induced hypertension, similar to AMI but at higher doses.
Conclusions:
- AMINO exhibits pharmacological actions comparable to AMI.
- AMINO functions as a 5-HT antagonist and inhibits noradrenaline uptake.
- Higher doses of AMINO are required to elicit effects similar to AMI.